Henry Cole - Global Medical Lead Independent Director
| GMRE Stock | USD 8.70 0.03 0.34% |
Director
Mr. Henry Cole is Lead Independent Director of Global Medical REIT Inc. Mr. Cole currently serves as President of Global Development International, LLC, a position he has held since 2007, where he provides development support, management and oversight for companies and varied program initiatives in medical and healthcare programs and products, including Instant Labs Medical Diagnostics, Inc., MedPharm, Inc., MPRC Group, LTD, and various others. Mr. Cole previously served from 1989 to 2005 as President and Corporationrationrate Officer at Futures Group International and Futures Group Holdings. Under his direction, corporate programs expanded to offices in over 40 countries including Washington, DC Hartford Chapel Hill, and Seattle Bath, England New Delhi, India Beijing, China Cairo, Egypt Johannesburg and Cape Town South Africa Accra, Ghana Ankara, Turkey Sao Palo, Brazil, Kiev and Odessa Ukraine, and others since 2017.
| Age | 76 |
| Tenure | 7 years |
| Address | 7373 Wisconsin Avenue, Bethesda, MD, United States, 20814 |
| Phone | 202 524 6851 |
| Web | https://www.globalmedicalreit.com |
Latest Insider Transactions
Cole has served on the boards of numerous organizations including the Millennium Project from 1996 to 2006; the Futures Institute for Sustainable Development from 2001 to 2005; Foundation Against HIV and AIDS from 2007 to 2011; Kids Save International from 2006 to 2012, Triple Win International from 2008 to 2013, and others. He has worked in over 28 countries worldwide, with indepth experience in Egypt, Turkey, Ghana, Cameroon, Kenya, Sudan, Sahelian Africa, Haiti, Trinidad, Bahamas, Philippines, Indonesia and India. His undergraduate studies were from Yale University and graduate studies from The John Hopkins University, both in economics.Global Medical Management Efficiency
The company has return on total asset (ROA) of 0.0171 % which means that it generated a profit of $0.0171 on every $100 spent on assets. This is way below average. Global Medical's management efficiency ratios could be used to measure how well Global Medical manages its routine affairs as well as how well it operates its assets and liabilities. At present, Global Medical's Return On Capital Employed is projected to slightly grow based on the last few years of reporting. The current year's Return On Assets is expected to grow to 0.02, whereas Return On Equity is forecasted to decline to 0.03. At present, Global Medical's Other Current Assets are projected to decrease significantly based on the last few years of reporting. The current year's Total Current Assets is expected to grow to about 71 M, whereas Non Currrent Assets Other are projected to grow to (424.6 K).Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Robert Webb | National Health Investors | 76 | |
| Stephen Plavin | Omega Healthcare Investors | 60 | |
| Robert Hensley | Community Healthcare Trust | 63 | |
| Jay Gellert | Ventas Inc | 66 | |
| Christann Vasquez | Healthcare Realty Trust | 60 | |
| Burke Whitman | Omega Healthcare Investors | 64 | |
| Robert Reed | Ventas Inc | 68 | |
| Robert Adams | National Health Investors | 74 | |
| Charlotte Swafford | National Health Investors | 73 | |
| Sean Nolan | Ventas Inc | 52 | |
| James Jobe | National Health Investors | 59 | |
| Nancy Agee | Healthcare Realty Trust | 68 | |
| Robert McCabe | National Health Investors | 70 | |
| Claire Gulmi | Community Healthcare Trust | 67 | |
| Edward Braman | Healthcare Realty Trust | 64 | |
| Melody Barnes | Ventas Inc | 56 | |
| Alan Gardner | Community Healthcare Trust | 67 | |
| Richard Gilchrist | Ventas Inc | 74 | |
| James Morey | Universal Health Realty | 52 | |
| Edward Lowenthal | Omega Healthcare Investors | 75 | |
| Matthew Lustig | Ventas Inc | 59 | |
Management Performance
| Return On Equity | 0.0072 | ||||
| Return On Asset | 0.0171 |
Global Medical REIT Leadership Team
Elected by the shareholders, the Global Medical's board of directors comprises two types of representatives: Global Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Global. The board's role is to monitor Global Medical's management team and ensure that shareholders' interests are well served. Global Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Global Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Henry Cole, Lead Independent Director | ||
| Matthew Cypher, Independent Director | ||
| Robert CPA, CFO Treasurer | ||
| Robert Kiernan, Chief Financial Officer, Treasurer | ||
| Jingguo Zhang, Director | ||
| Huiqi Zhang, Director | ||
| Jamie Barber, General Counsel, Secretary | ||
| Roscoe Moore, Independent Director | ||
| Stephen Swett, Investor Executive | ||
| Ronald Marston, Independent Director | ||
| Jeffery Busch, President Chairman | ||
| Jeffrey JD, President Chairman | ||
| Lori Wittman, Independent Director | ||
| Paula Crowley, Independent Director | ||
| Danica Holley, Chief Operating Officer | ||
| Mary Jensen, Investor Professional | ||
| Alfonzo Leon, Chief Investment Officer | ||
| Allen Webb, Senior Vice President - SEC Reporting and Technical Accounting | ||
| Jeffrey Busch, Chairman of the Board , President , Chief Executive Officer |
Global Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Global Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0072 | ||||
| Return On Asset | 0.0171 | ||||
| Profit Margin | 0.03 % | ||||
| Operating Margin | 0.26 % | ||||
| Current Valuation | 1.29 B | ||||
| Shares Outstanding | 66.8 M | ||||
| Shares Owned By Insiders | 5.65 % | ||||
| Shares Owned By Institutions | 62.99 % | ||||
| Number Of Shares Shorted | 1.2 M | ||||
| Price To Earning | 39.78 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Global Medical REIT is a strong investment it is important to analyze Global Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Global Medical's future performance. For an informed investment choice regarding Global Stock, refer to the following important reports:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Global Medical REIT. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Is Diversified REITs space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Global Medical. If investors know Global will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Global Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.43) | Dividend Share 0.84 | Earnings Share (0.02) | Revenue Per Share 2.082 | Quarterly Revenue Growth (0.04) |
The market value of Global Medical REIT is measured differently than its book value, which is the value of Global that is recorded on the company's balance sheet. Investors also form their own opinion of Global Medical's value that differs from its market value or its book value, called intrinsic value, which is Global Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Global Medical's market value can be influenced by many factors that don't directly affect Global Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Global Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Global Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Global Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.